Form4.ai tracks every SEC insider trade in real time. See every KURA insider filing with a free account — no card.

See every KURA insider filing

Free account

Kura Oncology, Inc. (KURA) Insider Trading

Kura Oncology, Inc. (KURA) has 10 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $2.4M, and 7 sales totalling $1.5M. Most recent filing: Sept. 29, 2026.

Bought vs sold

Open-market value, last 90 days

Bought: $2.4M (61%) Sold: $1.5M (39%)
  • Bought $2.4M · 61%
  • Sold $1.5M · 39%

What insiders filed

Form 4 filings by type, last 90 days

Buys: 2 (20%) Sales: 7 (70%) Grants, exercises & other: 1 (10%)
  • Buys 2 · 20%
  • Sales 7 · 70%
  • Grants, exercises & other 1 · 10%

At a glance

Insiders trading
7
Largest buy
—
Most recent filing
Sep 29, 2026

Latest KURA Form 4 filings

Date Insider Trade Value Price since buy
Sep 29, 2026 SEC filing Bair Teresa Brophy Chief Legal Officer Sold $88,618 —
Sep 29, 2026 SEC filing DOYLE THOMAS JAMES SVP, Finance & Accounting Sold $48,361 —
Sep 29, 2026 SEC filing FORD KATHLEEN Chief Operating Officer Sold $111,931 —

See every KURA insider trade

Create a free account to see all 10 KURA filings from the last 90 days. No card needed.

Create free account

Want KURA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.